Your browser doesn't support javascript.
Passive immunization against COVID-19 by anti-SARS-CoV-2 spike IgG in commercially available immunoglobulin preparations in severe antibody deficiency.
Hirsiger, Julia R; Weigang, Sebastian; Walz, Antje-Christine; Fuchs, Jonas; Daly, Mary-Louise; Eggimann, Stefan; Hausmann, Oliver; Schwemmle, Martin; Kochs, Georg; Panning, Marcus; Warnatz, Klaus; Recher, Mike; Berger, Christoph T.
  • Hirsiger JR; Translational Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Weigang S; Institute of Virology, Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Walz AC; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland.
  • Fuchs J; Institute of Virology, Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Daly ML; University Center for Immunology, University Hospital Basel, Basel, Switzerland.
  • Eggimann S; Swiss Society for Inborn Errors of Immunity, Zurich, Switzerland.
  • Hausmann O; ADR-AC GmbH, Adverse Drug Reactions-Analysis and Consulting, Bern, Switzerland; Löwenpraxis Luzern und Klinik St Anna, Lucerne, Switzerland.
  • Schwemmle M; Institute of Virology, Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Kochs G; Institute of Virology, Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Panning M; Institute of Virology, Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Warnatz K; Department of Rheumatology and Clinical Immunology, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Center for Chronic Immunodeficiency, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Recher M; University Center for Immunology, University Hospital Basel, Basel, Switzerland; Immunodeficiency Lab, Department Biomedicine, University of Basel, Basel, Switzerland.
  • Berger CT; Translational Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland; University Center for Immunology, University Hospital Basel, Basel, Switzerland. Electronic address: christoph.berger@usb.ch.
J Allergy Clin Immunol Pract ; 10(9): 2452-2455.e3, 2022 09.
Article in English | MEDLINE | ID: covidwho-1907245
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: English Journal: J Allergy Clin Immunol Pract Year: 2022 Document Type: Article Affiliation country: J.jaip.2022.06.020

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: English Journal: J Allergy Clin Immunol Pract Year: 2022 Document Type: Article Affiliation country: J.jaip.2022.06.020